1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Growing Public Awareness Of Autoimmune Disease 6.1.2 Improved Laboratory Automation 6.1.3 Partnerships With Physicians And Clinical Laboratories 6.1.4 Technological Advancements 6.1.5 Expansion In Coverage Allowed By Patient Protection And Affordable Care Act 6.2 Market Restraints 6.2.1 Slow Turnaround Time For Autoimmune Disease Diagnostic Test Results 6.2.2 High Frequency Of False Positive Result 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Disease Type 7.1.1 Systemic Autoimmune Disease 7.1.1.1 Rheumatoid Arthritis 7.1.1.2 Psoriasis 7.1.1.3 Systemic Lupus Erythematosus (SLE) 7.1.1.4 Multiple Sclerosis 7.1.1.5 Others 7.1.2 Localized Autoimmune Disease 7.1.2.1 Inflammatory Bowel disease 7.1.2.2 Type 1 Diabetes 7.1.2.3 Thyroid 7.1.2.4 Others 7.2 By Diagnosis 7.2.1 Immunofluorescence assays (IFA) 7.2.2 Enzyme-linked Immunosorbent Assay (ELISA) 7.2.3 Western Blotting 7.2.4 Dot blot 7.2.5 Line blot 7.2.6 Multiplex Immunoassay 7.2.7 Agglutination 7.2.8 Double Immune Diffusion 7.2.9 Counter Immune-electrophoresis 7.2.10 Others 7.3 By Geography 7.3.1 Asia-Pacific 7.3.1.1 China 7.3.1.2 Japan 7.3.1.3 India 7.3.1.4 Australia & New Zealand 7.3.1.5 South Korea 7.3.1.6 Rest of Asia-Pacific 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Abbott Laboratories 9.2 Bio-rad Laboratories 9.3 F. Hoffmann-la Roche 9.4 Myriad Genetics 9.5 Novartis AG 9.6 Siemens Healthineers Inc 9.7 Thermo Fisher Scientific *List Not Exhaustive 10. Future of the Market

F. Hoffmann-la Roche, Siemens Healthineers Inc, Novartis AG, Thermo Fisher Scientific, Myriad Genetics, Abbott Laboratories, Bio-rad Laboratories